Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Levewel 500
Levewel 500 is a broad-spectrum antiepileptic medication containing Levetiracetam 500 mg, designed to provide reliable seizure control. It is indicated for partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in adults and pediatric patients. With its unique mechanism of action and high tolerability, Levewel 500 is a trusted solution in epilepsy management.
Uses of Levewel 500
Levewel 500 is prescribed for the treatment of:
Partial-onset seizures (with or without secondary generalization)
Myoclonic seizures in patients with juvenile myoclonic epilepsy
Generalized tonic-clonic seizures in idiopathic generalized epilepsy
Benefits of Levewel 500
Effective Seizure Control: Reduces seizure frequency and severity
Minimal Drug Interactions: Suitable for use with other antiepileptic drugs
Well-Tolerated: Lower risk of sedation and cognitive impairment
Convenient Dosing: Oral formulation with good bioavailability
Mechanism of Action of Levewel 500
Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and preventing excessive neuronal excitability. This unique mechanism stabilizes neural activity, reducing the occurrence of seizures without affecting normal brain function.